Enterotoxin STp (E. coli) provides a compact peptide framework widely used to examine bacterial signaling and host-microbe interactions. Its disulfide-stabilized fold serves as a model for studying peptide rigidity and receptor activation. Researchers employ it to analyze guanylate-associated pathways and conformational determinants of microbial peptides. Utility extends to molecular recognition, toxin motif mapping, and sequence engineering.
CAT No: R2614
CAS No:115474-04-9
Synonyms/Alias:Enterotoxin STp (E. coli);115474-04-9;ENTEROTOXIN STP (E COLI);Enterotoxin STp (E. coli) trifluoroacetate salt;Enterotoxin stp(e coli);DA-73129;FE109770;H-Asn-Thr-Phe-Tyr-Cys-Cys-Glu-Leu-Cys-Cys-Asn-Pro-Ala-Cys-Ala-Gly-Cys-Tyr-OH; H-NTFYCCELCCNPACAGCY-OH;
Enterotoxin STp (E. coli), also known as heat-stable enterotoxin type p, is a peptide toxin produced by certain strains of Escherichia coli. Characterized by its resistance to heat denaturation, Enterotoxin STp is a small, cysteine-rich peptide that exhibits potent biological activity by interacting with specific cellular receptors. Its mechanism of action involves the activation of guanylate cyclase C on the surface of intestinal epithelial cells, leading to an increase in cyclic GMP levels and subsequent physiological effects. Due to its defined structure and robust activity, STp is widely utilized in scientific research to unravel the molecular basis of enterotoxigenic E. coli (ETEC) pathogenesis and to model gastrointestinal signaling pathways. The unique biochemical properties and well-characterized sequence of this toxin make it an indispensable reagent in both basic and applied research settings.
Pathogenesis Studies: Enterotoxin STp (E. coli) plays a pivotal role in the study of ETEC-induced diarrheal disease mechanisms. Researchers employ this peptide to mimic the pathogenic effects observed during natural infections, allowing for detailed investigations into host-pathogen interactions. By exposing cultured intestinal cells or animal tissues to STp, scientists can observe downstream effects such as altered ion transport, water secretion, and disruption of tight junction integrity. These insights are crucial for identifying molecular targets involved in the onset and progression of diarrheal symptoms, thereby advancing the broader understanding of bacterial enterotoxins in gastrointestinal disease models.
Signal Transduction Research: The heat-stable enterotoxin serves as a powerful tool for exploring guanylate cyclase C-mediated signaling pathways. By binding specifically to this receptor, the toxin induces a cascade of intracellular events that elevate cyclic GMP concentrations, ultimately affecting cellular ion transport and fluid balance. Utilizing STp in controlled experimental systems enables researchers to dissect the intricacies of cGMP signaling, uncovering the roles of downstream effectors such as protein kinase G and ion channels. These studies are instrumental in elucidating fundamental physiological processes and in identifying potential intervention points for modulating epithelial function.
Drug Discovery and Screening: Synthetic STp is frequently incorporated into in vitro assays aimed at screening novel inhibitors or modulators of guanylate cyclase C activity. By establishing a reproducible model of toxin-induced cGMP elevation, pharmaceutical researchers can evaluate the efficacy of candidate compounds in blocking or attenuating the toxin's action. This approach accelerates the identification of molecules with therapeutic potential to counteract ETEC-mediated effects or to regulate intestinal fluid homeostasis. The use of STp in high-throughput screening platforms thus facilitates the early-stage development of targeted agents for gastrointestinal disorders.
Vaccine Research: The immunogenic properties of Enterotoxin STp have made it a focus of vaccine development efforts targeting enterotoxigenic E. coli. By incorporating the peptide or its epitopes into vaccine formulations, researchers aim to elicit protective immune responses that neutralize the toxin's activity. Experimental immunization protocols utilizing STp as an antigenic component help delineate the nature and specificity of antibody-mediated neutralization. These investigations provide valuable data for optimizing vaccine design and for assessing the feasibility of toxin-based immunoprophylaxis strategies in preclinical models.
Diagnostic Tool Development: The unique sequence and biological activity of STp are harnessed in the creation of sensitive diagnostic assays for ETEC detection. By integrating the toxin into immunoassays or biosensor platforms, researchers can develop tests that reliably identify the presence of enterotoxigenic E. coli in clinical or environmental samples. Such diagnostic tools are essential for monitoring outbreaks, guiding epidemiological studies, and supporting food safety initiatives. The specificity of STp-based detection systems enhances the accuracy of pathogen identification, contributing to improved public health surveillance and response.
In summary, Enterotoxin STp (E. coli) occupies a central position in gastrointestinal research by enabling detailed studies of bacterial pathogenesis, signal transduction, and host response mechanisms. Its application extends to drug discovery, where it serves as a benchmark for evaluating new therapeutic agents, and to vaccine development, where it aids in the design of immunogenic constructs targeting ETEC. Additionally, the toxin's distinctive properties underpin the development of advanced diagnostic assays for rapid and reliable pathogen detection. As scientific inquiry into enterotoxigenic E. coli and related enterotoxins continues to expand, the use of STp remains integral to advancing both basic and translational research in the field of microbial pathogenesis and gastrointestinal biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.